Pathways Center Meriwether County MHAD
-
Services:
- Substance use treatment
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Screening for substance use
- Comprehensive mental health assessment
- Outreach to persons in the community
- Comprehensive substance use assessment
- Screening for tobacco use
- Screening for mental disorders
- HIV testing
- Drug or alcohol urine screening
- TB screening
- STD testing
- Commission on Accreditation of Rehabilitation Facilities (CARF)
- State department of health
- This facility administers/prescribes medication for alcohol use disorder
- State government
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Vaping permitted in designated area
- Hepatitis education, counseling, or support
- Substance use disorder education
- Family counseling
- Health education services other than HIV/AIDS or hepatitis
- Group counseling
- Marital/couples counseling
- HIV or AIDS education, counseling, or support
- Individual counseling
- Regular outpatient treatment
- Outpatient
- Outpatient methadone/buprenorphine or naltrexone treatment
- Discharge Planning
- Aftercare/continuing care
- Naloxone and overdose education
- Adult men
- Clients with co-occurring mental and substance use disorders
- Adolescents
- Adult women
- Criminal justice (other than DUI/DWI)/Forensic clients
- Clients who have experienced trauma
- Sliding fee scale (fee is based on income and other factors)
- Mental health services
- Suicide prevention services
- Early intervention for HIV
- Social skills development
- Case management service
- Spanish
- Sign language services for the deaf and hard of hearing
- Mentoring/peer support
- Assistance with obtaining social services
- Employment counseling or training
- Housing services
- Other contracted prescribing entity
- Prescribes naltrexone
- Buprenorphine maintenance
- Maintenance service with medically supervised withdrawal after stabilization
- Relapse prevention with naltrexone
- Adults
- Children/Adolescents
- Smoking permitted in designated area
- Naltrexone (oral)
- Medication for mental disorders
- Nicotine replacement
- Naltrexone (extended-release, injectable)
- Buprenorphine with naloxone
- Acamprosate (Campral®)
- Non-nicotine smoking/tobacco cessation
- Clonidine
- Buprenorphine (extended-release, injectable)
- Buprenorphine without naloxone
- Private health insurance
- State-financed health insurance plan other than Medicaid
- Medicare
- Cash or self-payment
- Medicaid
- Federal, or any government funding for substance use treatment programs
- Federal military insurance (e.g., TRICARE)
- Matrix Model
- Substance use disorder counseling
- Telemedicine/telehealth therapy
- Cognitive behavioral therapy
- Motivational interviewing
- Relapse prevention
- Contingency management/motivational incentives
- Anger management
- Trauma-related counseling
- Female
- Male
Type of Care
Assessment/Pre-treatment
Testing
License/Certification/Accreditation
Type of Alcohol Use Disorder Treatment
Facility Operation (e.g., Private, Public)
Opioid Medications used in Treatment
Facility Vaping Policy
Education and Counseling Services
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Transitional Services
Special Programs/Groups Offered
Payment Assistance Available
Ancillary Services
Language Services
Recovery Support Services
External Source of Medications Used for Alcohol Use Disorder Treatment
Type of Opioid Treatment
Age Groups Accepted
Facility Smoking Policy
Pharmacotherapies
Payment/Insurance/Funding Accepted
Treatment Approaches
Gender Accepted






